- Senate passes Drug Quality and Security Act
- Study from NCPA sheds new light on med synchronization programs
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Walgreens collaborates with CDC on comprehensive HIV treatment model
NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson said Wednesday that patients applying for its HIV drug assistance program would have a more streamlined application process.
The J&J Patient Assistance Foundation announced that it had started using a new, common patient assistance program application for the drugs it offers, consolidating all the required information in one place. The new application is the result of a partnership between the company and six others, as well as federal agencies and public-health advocacy groups.
The company said the form would simplify access to medications for HIV/AIDS patients taking drugs from multiple manufacturers' patient assistance programs.